Stryker Corporation (NYSE:SYK) Price Target and Innovations Overview

Core Insights - Stryker Corporation is a leading medical technology company with a focus on innovative orthopedic products, and Jefferies analyst Matthew Taylor has set a price target of $465, indicating a potential upside of 21.76% from the current trading price of $381.89, maintaining a Buy rating [1][5] Product Innovations - Stryker showcased new orthopedic innovations at the American Academy of Orthopedic Surgeons' 2026 Annual Meeting, including the Triathlon knee implants, which enhance stability and address metal sensitivity [2][5] - The company expanded its Mako SmartRobotics platform and advanced its power tools portfolio with new offerings like the Mako Shoulder, RPS, and BPX and TPX HD tools, reflecting its commitment to innovation and customer-driven enhancements [3][5] Market Performance - Despite a recent dip in stock price, Stryker's market capitalization remains strong at approximately $146.1 billion, with stock fluctuations between a low of $380.87 and a high of $384.51, and a trading volume of 1,657,972 shares on the NYSE [4]